Xiaowen Qin (Pu Zhang)

ORCID

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 5

Top Venues

Journal of medicinal chemistry

Cancer medicine

Current drug delivery

This page only lists publications with an associated author ORCID identifier.

Publications

Xiaowen Qin, Heng Wang, Wentao Xu, Bin Zheng, Haibao Zhang, Qi Zhang, Yang Liu, Zhenghong Liu, Li Sun, Yixuan Mou, Cenchao Yao, Wei Zheng, Yiyang Chen, Chenkai Wang, Xuanyi Zhou, You-Qing Shen, Xiaowen Qin, Dahong Zhang
A Selective-Tumor-Penetrating Strategy via Unidirectional Direct Transfer for Intravesical Therapy of Bladder Cancer. Journal of medicinal chemistry 67 (6) (2024)
Xiaowen Qin, Heng Wang, Wentao Xu, Bin Zheng, Haibao Zhang, Qi Zhang, Yang Liu, Zhenghong Liu, Li Sun, Yixuan Mou, Cenchao Yao, Wei Zheng, Yiyang Chen, Chenkai Wang, Xuanyi Zhou, You-Qing Shen, Xiaowen Qin, Dahong Zhang
A Selective-Tumor-Penetrating Strategy via Unidirectional Direct Transfer for Intravesical Therapy of Bladder Cancer. Journal of medicinal chemistry 67 (6) (2024)
Xiaowen Qin, Heng Wang, Wentao Xu, Bin Zheng, Haibao Zhang, Qi Zhang, Yang Liu, Zhenghong Liu, Li Sun, Yixuan Mou, Cenchao Yao, Wei Zheng, Yiyang Chen, Chenkai Wang, Xuanyi Zhou, You-Qing Shen, Xiaowen Qin, Dahong Zhang
A Selective-Tumor-Penetrating Strategy via Unidirectional Direct Transfer for Intravesical Therapy of Bladder Cancer. Journal of medicinal chemistry (2024)
Zhenghong Liu, Li Sun, Bin Zheng, Heng Wang, Xiaowen Qin, Pu Zhang, Qijun Wo, Haichang Li, Yixuan Mou, Dahong Zhang, Shuai Wang
The value of ATAD3A as a potential biomarker for bladder cancer. Cancer medicine (2023)
Wentao Xu, Xiaowen Qin, Yang Liu, Jun Chen, Yuguang Wang
Advances in Enzyme-responsive Supramolecular In situ Self-assembled Peptide for Drug Delivery. Current drug delivery (2023)

Xiaowen Qin.css-eqlu8i{font-size:small;padding-left:4px;} (Pu Zhang)

Publication Activity (10 Years)

Top Topics

Top Venues

Xiaowen Qin (Pu Zhang)